CLINICAL_TRIALS
trial_result
· 2021-09-01
Clinical Trial Update: Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis [Phase 3]
Summary
Phase 3 trial assessing safety and efficacy of RPC1063 in moderate to severe ulcerative colitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED | Results posted: 2021-09-01